, Tracking Stock Market Picks
Enter Symbol:
Arena Pharmaceuticals, Inc. (ARNA) [hlAlert]

Mkt Underperform
up 71.32 %

Arena Pharmaceuticals, Inc. (ARNA) downgraded to Mkt Underperform with price target $1 by Rodman & Renshaw

Posted on: Friday,  Jul 16, 2010  10:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Underperform Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) on 07/16/2010, when the stock price was $4.54.
Since then, Arena Pharmaceuticals, Inc. has lost 41.63% as of 10/08/2015's recent price of $2.65.
If you would have followed this Rodman & Renshaw's recommendation on ARNA, you would have gained 71.32% of your investment in 1910 days.

Arena Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory, and metabolic diseases. Arena's most advanced product candidate, lorcaserin, is being investigated in a Phase three clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/16/2010 10:25 AM Sell
4.54 1.00
as of 12/31/2010
1 Week down  -9.82 %
1 Month down  -31.03 %
3 Months down  -21.01 %
1 YTD up  64.90 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/4/2010 8:25 AM Hold
9/18/2009 1:25 PM Sell
5.51 3.00
9/15/2009 8:25 AM Hold
6/24/2009 11:25 AM Buy
4.82 9.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy